A warning to managers of stock companies and supervisory institutions about the consequences of publishing conflicting financial information. Do not damage people's trust in the capital market with false information! The significant difference between the capital increase figure announced in the initial announcement of the Ezer company for immune products with the symbol "Kazer" and the explanatory report of the board of directors of this company has once again turned the need for accuracy and responsibility in the publication of financial information into a serious issue. While in the initial information a capital increase of 13,400% was proposed, the company's explanatory documents indicate a capital increase of 35%; A dispute, even if it is caused by a mistake in recording data, should not be ignored without a clear explanation and timely correction. Continue in the link below.

A warning to managers of stock companies and supervisory institutions about the consequences of publishing conflicting financial information. Do not damage people's trust in the capital market with false information! The significant difference between the capital increase figure announced in the initial announcement of the Ezer company for immune products with the symbol "Kazer" and the explanatory report of the board of directors of this company has once again turned the need for accuracy and responsibility in the publication of financial information into a serious issue. While in the initial information a capital increase of 13,400% was proposed, the company's explanatory documents indicate a capital increase of 35%; A dispute, even if it is caused by a mistake in recording data, should not be ignored without a clear explanation and timely correction. Continue in the link below.